Literature DB >> 19442735

The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis.

Lijun Wang1, Kamal Sharma, Gabriella Grisotti, Raymond P Roos.   

Abstract

Mutant superoxide dismutase type 1 (MTSOD1), the most common known cause of familial amyotrophic lateral sclerosis (FALS), is believed to cause FALS as a result of a toxicity of the protein. MTSOD1s with full dismutase enzymatic activity (e.g., G37R) and without any enzymatic activity (e.g., G85R) cause FALS, demonstrating that the ability of MTSOD1 to cause FALS is not dependent on the dismutase activity; however, it remains unclear whether MTSOD1 dismutase activity can influence disease phenotype. In the present study, we selectively knocked down G85R expression in particular cell types of G85R mice. Results following knockdown of G85R in motor neurons (MNs)/interneurons of G85R mice were similar to results from a published study involving knockdown of G37R in G37R mice; however, G85R knockdown in microglia/macrophages induced a prolonged early and late disease phase while G37R knockdown in the same cells only affected late phase. These results show that: (i) MN as well as non-MN expression of G85R, like G37R, has a significant effect on disease in transgenic mice - indicating the role of non-cell autonomous degeneration in both dismutase-active and inactive MTSOD1s. (ii) The effect of MTSOD1 expression in microglia/macrophages varies with different mutants, and may be influenced by the MTSOD1's dismutase activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442735      PMCID: PMC2706919          DOI: 10.1016/j.nbd.2009.05.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.

Authors:  Han-Xiang Deng; Yong Shi; Yoshiaki Furukawa; Hong Zhai; Ronggen Fu; Erdong Liu; George H Gorrie; Mohammad S Khan; Wu-Yen Hung; Eileen H Bigio; Thomas Lukas; Mauro C Dal Canto; Thomas V O'Halloran; Teepu Siddique
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.

Authors:  A M Clement; M D Nguyen; E A Roberts; M L Garcia; S Boillée; M Rule; A P McMahon; W Doucette; D Siwek; R J Ferrante; R H Brown; J-P Julien; L S B Goldstein; D W Cleveland
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

3.  Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.

Authors:  T Sato; T Nakanishi; Y Yamamoto; P M Andersen; Y Ogawa; K Fukada; Z Zhou; F Aoike; F Sugai; S Nagano; S Hirata; M Ogawa; R Nakano; T Ohi; T Kato; M Nakagawa; T Hamasaki; A Shimizu; S Sakoda
Journal:  Neurology       Date:  2005-11-16       Impact factor: 9.910

4.  LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons.

Authors:  K Sharma; H Z Sheng; K Lettieri; H Li; A Karavanov; S Potter; H Westphal; S L Pfaff
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

5.  Truncated wild-type SOD1 and FALS-linked mutant SOD1 cause neural cell death in the chick embryo spinal cord.

Authors:  Ghanashyam D Ghadge; Lijun Wang; Kamal Sharma; Anna Liza Monti; Vytas Bindokas; Fred J Stevens; Raymond P Roos
Journal:  Neurobiol Dis       Date:  2005-08-09       Impact factor: 5.996

6.  Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress.

Authors:  Wensheng Lin; April Kemper; Jeffrey L Dupree; Heather P Harding; David Ron; Brian Popko
Journal:  Brain       Date:  2006-02-27       Impact factor: 13.501

7.  Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice.

Authors:  K Fukada; S Nagano; M Satoh; C Tohyama; T Nakanishi; A Shimizu; T Yanagihara; S Sakoda
Journal:  Eur J Neurosci       Date:  2001-12       Impact factor: 3.386

8.  Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse.

Authors:  Lijun Wang; Han-Xiang Deng; Gabriella Grisotti; Hong Zhai; Teepu Siddique; Raymond P Roos
Journal:  Hum Mol Genet       Date:  2009-02-19       Impact factor: 6.150

9.  Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.

Authors:  D R Borchelt; M K Lee; H S Slunt; M Guarnieri; Z S Xu; P C Wong; R H Brown; D L Price; S S Sisodia; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 10.  Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses.

Authors:  Stefan I Liochev; Irwin Fridovich
Journal:  Free Radic Biol Med       Date:  2003-06-01       Impact factor: 7.376

View more
  41 in total

Review 1.  Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis.

Authors:  Katharina A Quinlan
Journal:  Integr Comp Biol       Date:  2011-10-11       Impact factor: 3.326

2.  Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function.

Authors:  Andreu Viader; Judith P Golden; Robert H Baloh; Robert E Schmidt; Daniel A Hunter; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 3.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 4.  Glial cells in amyotrophic lateral sclerosis.

Authors:  T Philips; J D Rothstein
Journal:  Exp Neurol       Date:  2014-05-22       Impact factor: 5.330

5.  Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Eiichi Tokuda; Shunsuke Watanabe; Eriko Okawa; Shin-ichi Ono
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.

Authors:  Weihua Zhao; David R Beers; Kristopher G Hooten; Douglas H Sieglaff; Aijun Zhang; Shanker Kalyana-Sundaram; Christopher M Traini; Wendy S Halsey; Ashley M Hughes; Ganesh M Sathe; George P Livi; Guo-Huang Fan; Stanley H Appel
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

7.  An enhanced integrated stress response ameliorates mutant SOD1-induced ALS.

Authors:  Lijun Wang; Brian Popko; Raymond P Roos
Journal:  Hum Mol Genet       Date:  2013-12-23       Impact factor: 6.150

Review 8.  Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Authors:  Rachna S Pandya; Haining Zhu; Wei Li; Robert Bowser; Robert M Friedlander; Xin Wang
Journal:  Cell Mol Life Sci       Date:  2013-07-18       Impact factor: 9.261

9.  Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells.

Authors:  Zhihui Zhong; Hristelina Ilieva; Lee Hallagan; Robert Bell; Itender Singh; Nicole Paquette; Meenakshisundaram Thiyagarajan; Rashid Deane; Jose A Fernandez; Steven Lane; Anna B Zlokovic; Todd Liu; John H Griffin; Nienwen Chow; Francis J Castellino; Konstantin Stojanovic; Don W Cleveland; Berislav V Zlokovic
Journal:  J Clin Invest       Date:  2009-10-19       Impact factor: 14.808

Review 10.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.